Search / Trial NCT06614478

Frailty, Hip Fractures and Inflammatory Biomarkers

Launched by UNIVERSITY OF THESSALY · Sep 23, 2024

Trial Information

Current as of October 09, 2024

Recruiting

Keywords

Description

Frailty (F) is a prevalent syndrome among elderly patient with hip fractures (HF) and has been linked to poor prognosis. Inflammatory biomarkers have been used as prognostic indexes in patients with HF. We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * age \>65 years, ASA PS I-III, non- institutionalized, able to communicate patients
  • Exclusion Criteria:
  • * Patients with severe cognitive dysfunction, those treated conservatively, those with pathological fractures and patients who refused to participate

About University Of Thessaly

The University of Thessaly is a distinguished academic institution located in Greece, recognized for its commitment to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials aimed at improving healthcare outcomes and fostering innovation in medical practices. Its dedicated research teams, equipped with state-of-the-art facilities and expertise across various fields, strive to contribute valuable insights to the scientific community while prioritizing patient safety and ethical standards in all clinical endeavors.

Locations

Larissa, Thessaly, Greece

Larissa, Thessaly, Greece

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0